Immunization with the first identified Plasmodium falciparum merozoite surface protein (MSP-
1) protected monkeys from an otherwise fatal infection. The question of whether the high …

The merozoite is the invasive form of the asexual stage of Plasmodium species. At least two
polymorphic glycoproteins have been found on its surface in the human malaria parasite …

We have studied the genetic polymorphism at 10 Plasmodium falciparum loci that are
considered potential targets for specific antimalarial vaccines. The polymorphism is …

Abstract Merozoite surface protein-1 (MSP-1) of Plasmodium falciparum is a malaria vaccine
candidate Ag. Immunity to MSP-1 has been implicated in protection against infection in …

The immunogenicity and protective efficacy of baculovirus recombinant polypeptide based
on the Plasmodium falciparum merozoite surface protein 1 (MSP-1) has been evaluated in …

A PROMINENT FEATURE of host responses to infection with malaria parasites is an
antibody response that includes specificities to a large number of different protein antigens …

Apical membrane antigen 1 (AMA-1) is a promising vaccine candidate for Plasmodium
falciparum malaria. Antibodies against AMA-1 of P. falciparum (PfAMA-1) interrupt merozoite …

The highly attenuated NYVAC vaccinia virus strain has been utilized to develop a
multiantigen, multistage vaccine candidate for malaria, a disease that remains a serious …

The occurrence of multiple-clone Plasmodium falciparum haploid blood-stage infections is a
pre-requisite for cross-fertilization and genetic exchange at the diploid stage in the mosquito …

The C-terminal proteolytic processing product of merozoite surface protein 1 (MSP1)
appears essential for successful erythrocyte invasion by the malarial parasite, Plasmodium …